Understanding the characteristics of primary liver cancer
A Single Center, Retrospective Clinical Study on the Clinical Characteristics of Primary Liver Cancer
This study looks at the traits and outlook of primary liver cancer in adults to see how factors like infections and health conditions affect the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Trial ID | NCT06325267 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the clinical characteristics and prognosis of primary liver cancer (PLC), which is a significant global health issue. It focuses on identifying risk factors associated with PLC, including viral infections and metabolic conditions. By analyzing data from patients diagnosed with PLC, the study seeks to enhance understanding of disease progression and inform monitoring and treatment strategies. The study will include patients aged 18 and older who have been diagnosed with PLC through imaging or pathology.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have received an initial diagnosis of primary liver cancer.
Not a fit: Patients with other types of malignant tumors or severe comorbidities such as mental illness or organ dysfunction may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and treatment strategies for patients with primary liver cancer.
How similar studies have performed: While there have been studies on liver cancer, this specific observational approach focusing on clinical characteristics and risk factors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years or older; 2. initial diagnosis of primary liver cancer based on enhanced CT or enhanced MRI or pathology Exclusion Criteria: 1. other types of malignant tumors; 2. mental illness, severe cardiopulmonary dysfunction, severe renal insufficiency, serious infection and cerebrovascular accident; 3. received liver transplant or other organ transplant.
Where this trial is running
Nanjing, Jiangsu
- Nanjing Drum Tower Hospital — Nanjing, Jiangsu, China (Recruiting)
Study contacts
- Study coordinator: Jie Li, M.D.,Ph.D
- Email: lijier@nju.edu.cn
- Phone: 15863787910
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.